Aaron J. Kosar

Array ( [id] => 5342365 [patent_doc_number] => 20090181015 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-16 [patent_title] => 'HUMANIZED ANTI-CD40 ANTIBODIES AND THEIR METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 11/913305 [patent_app_country] => US [patent_app_date] => 2006-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 30019 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20090181015.pdf [firstpage_image] =>[orig_patent_app_number] => 11913305 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5538715 [patent_doc_number] => 20090220520 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'Recombinant method for the production of a monoclonal antibody to CD52 for the treatment of chronic lymphocytic leukemia' [patent_app_type] => utility [patent_app_number] => 11/914752 [patent_app_country] => US [patent_app_date] => 2006-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 3852 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20090220520.pdf [firstpage_image] =>[orig_patent_app_number] => 11914752 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5624853 [patent_doc_number] => 20060263358 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-23 [patent_title] => 'Method for reducing sepsis or cardiogenic shock associated with myocardial injury' [patent_app_type] => utility [patent_app_number] => 11/436440 [patent_app_country] => US [patent_app_date] => 2006-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3706 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20060263358.pdf [firstpage_image] =>[orig_patent_app_number] => 11436440 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5415886 [patent_doc_number] => 20090041773 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-12 [patent_title] => 'METHODS FOR DIAGNOSIS AND TREATMENT OF PROLIFERATIVE DISORDERS MEDIATED BY CD40 SIGNALING' [patent_app_type] => utility [patent_app_number] => 11/914714 [patent_app_country] => US [patent_app_date] => 2006-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 44750 [patent_no_of_claims] => 116 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20090041773.pdf [firstpage_image] =>[orig_patent_app_number] => 11914714 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8559908 [patent_doc_number] => 08333970 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-18 [patent_title] => 'Methods of monitoring the efficacy of anti-CD40 antibodies in treating a subject having an inflammatory or autoimmune disease' [patent_app_type] => utility [patent_app_number] => 11/914710 [patent_app_country] => US [patent_app_date] => 2006-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 38633 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 357 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11914710 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5753500 [patent_doc_number] => 20060222649 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-05 [patent_title] => 'Methods for inducing antigen-specific T cell tolerance' [patent_app_type] => utility [patent_app_number] => 11/405876 [patent_app_country] => US [patent_app_date] => 2006-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 14135 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20060222649.pdf [firstpage_image] =>[orig_patent_app_number] => 11405876 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5198722 [patent_doc_number] => 20070298040 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-27 [patent_title] => 'Methods of treating seronegative arthropathy with anti-TNF antibodies' [patent_app_type] => utility [patent_app_number] => 11/401391 [patent_app_country] => US [patent_app_date] => 2006-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 52175 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20070298040.pdf [firstpage_image] =>[orig_patent_app_number] => 11401391 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5834243 [patent_doc_number] => 20060246073 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-02 [patent_title] => 'Anti-TNF antibodies and peptides of human tumor necrosis factor' [patent_app_type] => utility [patent_app_number] => 11/401337 [patent_app_country] => US [patent_app_date] => 2006-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 61878 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0246/20060246073.pdf [firstpage_image] =>[orig_patent_app_number] => 11401337 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5687774 [patent_doc_number] => 20060286089 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-21 [patent_title] => 'Compositions and methods for the treatment of burns and sepsis' [patent_app_type] => utility [patent_app_number] => 11/400071 [patent_app_country] => US [patent_app_date] => 2006-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 53 [patent_figures_cnt] => 53 [patent_no_of_words] => 39277 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20060286089.pdf [firstpage_image] =>[orig_patent_app_number] => 11400071 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5921392 [patent_doc_number] => 20060240017 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-26 [patent_title] => 'Human anti-TNF antibodies and peptides' [patent_app_type] => utility [patent_app_number] => 11/400787 [patent_app_country] => US [patent_app_date] => 2006-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 52086 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0240/20060240017.pdf [firstpage_image] =>[orig_patent_app_number] => 11400787 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5850604 [patent_doc_number] => 20060233795 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-19 [patent_title] => 'Methods for selectively modulating a Th2-type response within a population of activated CD4+ T cells' [patent_app_type] => utility [patent_app_number] => 11/388754 [patent_app_country] => US [patent_app_date] => 2006-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 21385 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20060233795.pdf [firstpage_image] =>[orig_patent_app_number] => 11388754 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5595762 [patent_doc_number] => 20060159678 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-20 [patent_title] => 'Modulators of cytokine mediated signaling pathways and integrin alphabeta3 receptor antagonists for combination therapy' [patent_app_type] => utility [patent_app_number] => 11/375305 [patent_app_country] => US [patent_app_date] => 2006-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5910 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0159/20060159678.pdf [firstpage_image] =>[orig_patent_app_number] => 11375305 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5784324 [patent_doc_number] => 20060204500 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-14 [patent_title] => 'Methods for modulating expression of an HIV-1 fusion cofactor' [patent_app_type] => utility [patent_app_number] => 11/373777 [patent_app_country] => US [patent_app_date] => 2006-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 18323 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20060204500.pdf [firstpage_image] =>[orig_patent_app_number] => 11373777 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5630978 [patent_doc_number] => 20060147446 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-06 [patent_title] => 'Humanized antibodies to human GP39, compositions, and therapeutic uses thereof' [patent_app_type] => utility [patent_app_number] => 11/370899 [patent_app_country] => US [patent_app_date] => 2006-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 18224 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20060147446.pdf [firstpage_image] =>[orig_patent_app_number] => 11370899 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5693690 [patent_doc_number] => 20060153837 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-13 [patent_title] => 'Treating autoimmune diseases with humanized anti-CD401 antibodies' [patent_app_type] => utility [patent_app_number] => 11/370898 [patent_app_country] => US [patent_app_date] => 2006-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 18446 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20060153837.pdf [firstpage_image] =>[orig_patent_app_number] => 11370898 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5753497 [patent_doc_number] => 20060222646 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-05 [patent_title] => 'Anti-TNFalpha antibodies in therapy of asthma' [patent_app_type] => utility [patent_app_number] => 11/366724 [patent_app_country] => US [patent_app_date] => 2006-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8903 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20060222646.pdf [firstpage_image] =>[orig_patent_app_number] => 11366724 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11263294 [patent_doc_number] => 09487581 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-11-08 [patent_title] => 'Anti-CTLA-4 antibody compositions' [patent_app_type] => utility [patent_app_number] => 11/817894 [patent_app_country] => US [patent_app_date] => 2006-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 54292 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11817894 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 531381 [patent_doc_number] => 07175843 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-02-13 [patent_title] => 'Methods for selectively stimulating proliferation of T cells' [patent_app_type] => utility [patent_app_number] => 11/366331 [patent_app_country] => US [patent_app_date] => 2006-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 29 [patent_no_of_words] => 19100 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/175/07175843.pdf [firstpage_image] =>[orig_patent_app_number] => 11366331 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5785447 [patent_doc_number] => 20060205069 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-14 [patent_title] => 'Compositions comprising a first agent which provides a primary activation signal to T cells and a second agent which stimulates an accessory molecule on the surface of T cells' [patent_app_type] => utility [patent_app_number] => 11/364102 [patent_app_country] => US [patent_app_date] => 2006-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 31545 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0205/20060205069.pdf [firstpage_image] =>[orig_patent_app_number] => 11364102 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5642284 [patent_doc_number] => 20060280739 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-14 [patent_title] => 'Novel human beta-2 integrin alpha subunit' [patent_app_type] => utility [patent_app_number] => 11/358915 [patent_app_country] => US [patent_app_date] => 2006-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 61574 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20060280739.pdf [firstpage_image] =>[orig_patent_app_number] => 11358915 [rel_patent_id] =>[rel_patent_doc_number] =>)